摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-5-methyl-2-[2-(1-naphthyl)-vinyl]-4-piperidinopyridine hydrochloride

中文名称
——
中文别名
——
英文名称
(E)-5-methyl-2-[2-(1-naphthyl)-vinyl]-4-piperidinopyridine hydrochloride
英文别名
5-methyl-2-[(E)-2-naphthalen-1-ylethenyl]-4-piperidin-1-ylpyridine;hydrochloride
(E)-5-methyl-2-[2-(1-naphthyl)-vinyl]-4-piperidinopyridine hydrochloride化学式
CAS
——
化学式
C23H24N2*ClH
mdl
——
分子量
364.918
InChiKey
FIRAEJACZMKMQE-UEIGIMKUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.13
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    16.1
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    (1-萘甲基)三苯基氯化磷正己烷正丁基锂5-methyl-4-piperidino-2-pyridinecarbaldehyde 、 在 氮气四氢呋喃乙醚氯化钠magnesium sulfate正己烷三苯基氧化膦 、 crude mixture 、 ethyl acetate n-hexane乙醇盐酸methanol diethyl ether 作用下, 以 四氢呋喃 为溶剂, 反应 1.5h, 以to give 4.5 g (yield 41%) of the captioned compound (14-A) and 3.7 g (yield 37%) of the captioned compound (14-B) as crystals的产率得到(E)-5-methyl-2-[2-(1-naphthyl)-vinyl]-4-piperidinopyridine hydrochloride
    参考文献:
    名称:
    Anti-ulcer substituted pyridine derivatives
    摘要:
    一种被表示为通式##STR1##的取代吡啶衍生物,其中R.sup.1代表苯基或萘基,可选地被选自氢氧基、较低的烷基、较低的烷氧基、环烷基、较低的烷氧羰基、苯基和卤素原子的取代基取代; X代表氧原子、硫原子、羰基或式为--CH(OH)--或--N(R.sup.a)--的基团,其中R.sup.a是氢原子或较低的烷基; Y代表线性或支链较低的烷基或乙烯基,可选地被较低的烷基取代,但当X为氧或硫原子时,Y代表较低的烷基; R.sup.2和R.sup.3相同或不同,分别代表氢原子或较低的烷基; R.sup.4代表氢原子、较低的烷氧基、环烷氧基、较低的烷硫基、环烷硫基、芳氧基、芳基烷氧基或式为##STR2##的基团,其中R.sup.b和R.sup.c相同或不同,分别代表氢原子或较低的烷基。或R.sup.b和R.sup.c连同相邻的氮原子可以形成5-至7-成员饱和杂环环,该环可选地包含至少一种来自氧、硫和氮原子的其他杂原子,并可选地被较低的烷基取代; m和n分别为0或1,但m和n不能同时为0,或其酸加成盐。该化合物是一种抗溃疡剂。
    公开号:
    US04839353A1
点击查看最新优质反应信息

文献信息

  • Substituted pyridine derivatives
    申请人:BANYU PHARMACEUTICAL CO., LTD.
    公开号:EP0264883A2
    公开(公告)日:1988-04-27
    A substituted pyridine derivative represented by the general formula herein R¹ represents a phenyl or naphthyl group which may optionally be substituted by a substituent selected from the class consisting of a hydroxyl group, lower alkyl groups, lower alkoxy groups, cycloalkyl groups, lower alkoxycarbonyl groups, a phenyl group and halogen atoms; X represents an oxygen atom, a sulfur atom, a carbonyl group, or a group of the formula -CH(OH)- or -N(Ra)- in which Ra is hydrogen atom or a lower alkyl group; Y represents a linear or branched lower alkylene group or a vinylene group which may optionally be substituted by a lower alkyl group, with the proviso that when X is an oxygen or sulfur atom, Y represents the lower alkylene group. R² and R³ are identical or different and each represents a hydrogen atom or a lower alkyl group; R⁴ represents a hydrogen atom, a lower alkoxy group, a cycloalkyloxy group, a lower alkylthio group, a cycloalkylthio group, an aryloxy group, an aralkyloxy group or a group of the formula in which Rb and Rc are identical or different and each represents a hydrogen atom or a lower alkyl group, or Rb and Rc, taken together, may form together with the adjacent nitrogen atom a 5- to 7-membered saturated heterocyclic ring which may optionally contain at least one additional hetero atom selected from the group con­sisting of oxygen, sulfur and nitrogen atoms and may optionally be substituted by a lower alkyl group; m and n are each 0 or 1, with the proviso that m and n are not 0 at the same time, or an acid addition salt thereof. This compound is useful as an antiulcer agent.
    通式如下的取代吡啶衍生物 其中 R¹ 代表苯基或萘基,可任选被选自羟基、低级烷基、低级烷氧基、环烷基、低级烷氧羰基、苯基和卤素原子的取代基取代;X 代表氧原子、硫原子、羰基或式-CH(OH)-或-N(Ra)-的基团,其中 Ra 为氢原子或低级烷基;Y 代表直链或支链低级亚烷基或乙烯基,可选择被低级烷基取代,但当 X 为氧原子或硫原子时,Y 代表低级亚烷基。R² 和 R³ 相同或不同,各自代表氢原子或低级烷基;R⁴ 代表氢原子、低级烷氧基、环烷氧基、低级烷硫基、环烷硫基、芳氧基、芳烷氧基或式 其中 Rb 和 Rc 相同或不同,且各自代表一个氢原子或一个低级烷基,或 Rb 和 Rc 合在一起,可与相邻的氮原子一起形成一个 5 至 7 元饱和杂环,该杂环可任选包含至少一个选自氧、硫和氮原子组成的组的额外杂原子,并可任选被一个低级烷基取代;m 和 n 各为 0 或 1,但 m 和 n 不能同时为 0,或其酸加成盐。该化合物可用作抗溃疡剂。
  • US4839353A
    申请人:——
    公开号:US4839353A
    公开(公告)日:1989-06-13
  • Anti-ulcer substituted pyridine derivatives
    申请人:Banyu Pharmaceutical Co., Ltd.
    公开号:US04839353A1
    公开(公告)日:1989-06-13
    A substituted pyridine derivative represented by the general formula ##STR1## wherein R.sup.1 represents a phenyl or naphthyl group which may optionally be substituted by a substituent selected from the class consisting of a hydroxyl group, lower alkyl groups, lower alkoxy groups, cycloalkyl groups, lower alkoxycarbonyl groups, a phenyl group and halogen atoms; X represents an oxygen atom, a sulfur atom, a carbonyl group, or a group of the formula --CH(OH)-- or --N(R.sup.a)-- in which R.sup.a is a hydrogen atom or a lower alkyl group; Y represents a linear or branched lower alkylene group or a vinylene group which may optionally be substituted by a lower alkyl group, with the proviso that when X is an oxygen or sulfur atom, Y represents the lower alkylene group; R.sup.2 and R.sup.3 are identical or different and each represents a hydrogen atom or a lower alkyl group; R.sup.4 represents a hydrogen atom, a lower alkoxy group, a cycloalkyloxy group, a lower alkylthio group, a cycloalkylthio group, an aryloxy group, an aralkyloxy groups or a group of the formula ##STR2## in which R.sup.b and R.sup.c are identical or different and each represents a hydrogen atom or a lower alkyl group. or R.sup.b and R.sup.c, taken together, may form together with the adjacent nitrogen atom a 5- to 7-membered saturated heterocyclic ring which may optionally contain at least one additional hetero atom selected from the group consisting of oxygen, sulfur and nitrogen atoms and may optionally be substituted by a lower alkyl group; m and n are each 0 or 1, with the proviso that m and n are not 0 at the same time, or an acid addition salt thereof. This compound is useful as an antiulcer agent.
    一种被表示为通式##STR1##的取代吡啶衍生物,其中R.sup.1代表苯基或萘基,可选地被选自氢氧基、较低的烷基、较低的烷氧基、环烷基、较低的烷氧羰基、苯基和卤素原子的取代基取代; X代表氧原子、硫原子、羰基或式为--CH(OH)--或--N(R.sup.a)--的基团,其中R.sup.a是氢原子或较低的烷基; Y代表线性或支链较低的烷基或乙烯基,可选地被较低的烷基取代,但当X为氧或硫原子时,Y代表较低的烷基; R.sup.2和R.sup.3相同或不同,分别代表氢原子或较低的烷基; R.sup.4代表氢原子、较低的烷氧基、环烷氧基、较低的烷硫基、环烷硫基、芳氧基、芳基烷氧基或式为##STR2##的基团,其中R.sup.b和R.sup.c相同或不同,分别代表氢原子或较低的烷基。或R.sup.b和R.sup.c连同相邻的氮原子可以形成5-至7-成员饱和杂环环,该环可选地包含至少一种来自氧、硫和氮原子的其他杂原子,并可选地被较低的烷基取代; m和n分别为0或1,但m和n不能同时为0,或其酸加成盐。该化合物是一种抗溃疡剂。
查看更多